Transcription control of DAPK

Apoptosis

Volumn 19, Issue 2, 2014, Pages 298-305

  Benderska, Natalya ^a   Schneider Stock, Regine ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Apoptosis; Cancer; DAPK; Methylation; Transcription factor

Indexed keywords

ALTERNATIVE SPLICING; ANIMALS; APOPTOSIS; DEATH-ASSOCIATED PROTEIN KINASES; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 84894997412     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-013-0931-6     Document Type: Review

References (79)

1. Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A (1995) Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev 9(1):15-30
2. Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, Eisenbach L, Kimchi A (1997) DAP kinase links the control of apoptosis to metastasis. Nature 390(6656):180-184. doi: 10.1038/36599
3. Cohen O, Inbal B, Kissil JL, Raveh T, Berissi H, Spivak-Kroizaman T, Feinstein E, Kimchi A (1999) DAP-kinase participates in TNF-alpha- and Fas-induced apoptosis and its function requires the death domain. J Cell Biol 146(1):141-148
4. Jang CW, Chen CH, Chen CC, Chen JY, Su YH, Chen RH (2002) TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nature cell biology 4(1):51-58. doi: 10.1038/ncb731ncb731
5. Chen T, Li E (2004) Structure and function of eukaryotic DNA methyltransferases. Current topics in developmental biology 60:55-89. doi: 10.1016/S0070-2153(04)60003-2
6. Gardiner-Garden M, Frommer M (1987) CpG islands in vertebrate genomes. J Mol Biol 196(2):261-282
7. Antequera F, Bird A (1993) Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci USA 90(24):11995-11999
8. Cross SH, Bird AP (1995) CpG islands and genes. Curr Opin Genet Dev 5(3):309-314
9. Wutz A, Smrzka OW, Schweifer N, Schellander K, Wagner EF, Barlow DP (1997) Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature 389(6652):745-749. doi: 10.1038/39631
10. Lee JT (2003) Molecular links between X-inactivation and autosomal imprinting: X-inactivation as a driving force for the evolution of imprinting? Curr Biol 13(6):R242-R254
11. Feinberg AP, Tycko B (2004) The history of cancer epigenetics. Nat Rev Cancer 4(2):143-153. doi: 10.1038/nrc1279
12. Pulling LC, Grimes MJ, Damiani LA, Juri DE, Do K, Tellez CS, Belinsky SA (2009) Dual promoter regulation of death-associated protein kinase gene leads to differentially silenced transcripts by methylation in cancer. Carcinogenesis 30(12):2023-2030. doi: 10.1093/carcin/bgp276
13. Kuester D, Guenther T, Biesold S, Hartmann A, Bataille F, Ruemmele P, Peters B, Meyer F, Schubert D, Bohr UR, Malfertheiner P, Lippert H, Silver AR, Roessner A, Schneider-Stock R (2010) Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma. Pathol Res Pract 206(9):616-624. doi: 10.1016/j.prp.2010.05.004
14. Chakilam S, Gandesiri M, Rau TT, Agaimy A, Vijayalakshmi M, Ivanovska J, Wirtz RM, Schulze-Luehrmann J, Benderska N, Wittkopf N, Chellappan A, Ruemmele P, Vieth M, Rave-Frank M, Christiansen H, Hartmann A, Neufert C, Atreya R, Becker C, Steinberg P, Schneider-Stock R (2013) Death-associated protein kinase controls STAT3 activity in intestinal epithelial cells. Am J Pathol 182(3):1005-1020. doi: 10.1016/j.ajpath.2012.11.026
15. Mittag F, Kuester D, Vieth M, Peters B, Stolte B, Roessner A, Schneider-Stock R (2006) DAPK promotor methylation is an early event in colorectal carcinogenesis. Cancer Lett 240(1):69-75. doi: 10.1016/j.canlet.2005. 08.034
16. Brait M, Loyo M, Rosenbaum E, Ostrow KL, Markova A, Papagerakis S, Zahurak M, Goodman SM, Zeiger M, Sidransky D, Umbricht CB, Hoque MO (2012) Correlation between BRAF mutation and promoter methylation of TIMP3, RARbeta2 and RASSF1A in thyroid cancer. Epigenetics 7(7):710-719. doi: 10.4161/epi.20524
17. Kissil JL, Feinstein E, Cohen O, Jones PA, Tsai YC, Knowles MA, Eydmann ME, Kimchi A (1997) DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene. Oncogene 15(4):403-407. doi: 10.1038/sj.onc.1201172
18. Ng MH (2002) Death associated protein kinase: from regulation of apoptosis to tumor suppressive functions and B cell malignancies. Apoptosis 7(3):261-270
19. Reddy AN, Jiang WW, Kim M, Benoit N, Taylor R, Clinger J, Sidransky D, Califano JA (2003) Death-associated protein kinase promoter hypermethylation in normal human lymphocytes. Cancer Res 63(22):7694-7698
20. Brabender J, Arbab D, Huan X, Vallbohmer D, Grimminger P, Ling F, Neiss S, Bollschweiler E, Schneider PM, Holscher AH, Metzger R (2009) Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer. Ann Surg Oncol 16(5):1378-1383. doi: 10.1245/s10434-009-0356-1
21. Kaufmann SH, Earnshaw WC (2000) Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256(1):42-49. doi: 10.1006/excr.2000.4838
22. Tang X, Khuri FR, Lee JJ, Kemp BL, Liu D, Hong WK, Mao L (2000) Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J Natl Cancer Inst 92(18):1511-1516
23. Kim DH, Nelson HH, Wiencke JK, Christiani DC, Wain JC, Mark EJ, Kelsey KT (2001) Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer. Oncogene 20(14):1765-1770. doi: 10.1038/sj.onc. 1204302
24. Levy D, Plu-Bureau G, Decroix Y, Hugol D, Rostene W, Kimchi A, Gompel A (2004) Death-associated protein kinase loss of expression is a new marker for breast cancer prognosis. Clin Cancer Res 10(9):3124-3130
25. Sanchez-Cespedes M, Esteller M, Wu L, Nawroz-Danish H, Yoo GH, Koch WM, Jen J, Herman JG, Sidransky D (2000) Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60(4):892-895
26. Puto LA, Reed JC (2008) Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Genes Dev 22(8):998-1010. doi: 10.1101/gad.1632208
27. Bialik S, Kimchi A (2006) The death-associated protein kinases: structure, function, and beyond. Annu Rev Biochem 75:189-210. doi: 10.1146/annurev.biochem.75.103004.142615
28. Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen SS, Hackanson B, Grever MR, Lucas DM, Matkovic JJ, Lin TS, Kipps TJ, Murray F, Weisenburger D, Sanger W, Lynch J, Watson P, Jansen M, Yoshinaga Y, Rosenquist R, de Jong PJ, Coggill P, Beck S, Lynch H, de la Chapelle A, Plass C (2007) Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129(5):879-890. doi: 10.1016/j.cell.2007.03.043
29. Martoriati A, Doumont G, Alcalay M, Bellefroid E, Pelicci PG, Marine JC (2005) dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53. Oncogene 24(8):1461-1466. doi: 10.1038/sj.onc.1208256
30. Croniger C, Trus M, Lysek-Stupp K, Cohen H, Liu Y, Darlington GJ, Poli V, Hanson RW, Reshef L (1997) Role of the isoforms of CCAAT/enhancer-binding protein in the initiation of phosphoenolpyruvate carboxykinase (GTP) gene transcription at birth. J Biol Chem 272(42):26306-26312
31. Darlington GJ, Ross SE, MacDougald OA (1998) The role of C/EBP genes in adipocyte differentiation. J Biol Chem 273(46):30057-30060
32. Seagroves TN, Krnacik S, Raught B, Gay J, Burgess-Beusse B, Darlington GJ, Rosen JM (1998) C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev 12(12):1917-1928
33. Poli V (1998) The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 273(45):29279-29282
34. Akira S, Kishimoto T (1997) NF-IL6 and NF-kappa B in cytokine gene regulation. Adv Immunol 65:1-46
35. Kalvakolanu DV (2003) Alternate interferon signaling pathways. Pharmacol Ther 100(1):1-29
36. Lekstrom-Himes J, Xanthopoulos KG (1998) Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 273(44):28545-28548
37. Gade P, Roy SK, Li H, Nallar SC, Kalvakolanu DV (2008) Critical role for transcription factor C/EBP-beta in regulating the expression of death-associated protein kinase 1. Mol Cell Biol 28(8):2528-2548. doi: 10.1128/MCB.00784-07
38. Anjum R, Roux PP, Ballif BA, Gygi SP, Blenis J (2005) The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling. Curr Biol 15(19):1762-1767. doi: 10.1016/j.cub.2005.08.050
39. Chen CH, Wang WJ, Kuo JC, Tsai HC, Lin JR, Chang ZF, Chen RH (2005) Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK. EMBO J 24(2):294-304. doi: 760051010.1038/sj.emboj.7600510
40. Massague J, Seoane J, Wotton D (2005) Smad transcription factors. Genes Dev 19(23):2783-2810. doi: 10.1101/gad.1350705
41. Shanmugam R, Gade P, Wilson-Weekes A, Sayar H, Suvannasankha A, Goswami C, Li L, Gupta S, Cardoso AA, Al Baghdadi T, Sargent KJ, Cripe LD, Kalvakolanu DV, Boswell HS (2012) A noncanonical Flt3ITD/NF-kappaB signaling pathway represses DAPK1 in acute myeloid leukemia. Clin Cancer Res 18(2):360-369. doi: 10.1158/1078-0432.CCR-10-3022
42. Hayakawa J, Mittal S, Wang Y, Korkmaz KS, Adamson E, English C, Ohmichi M, McClelland M, Mercola D (2004) Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. Mol Cell 16(4):521-535. doi: 10.1016/j.molcel.2004.10.024
43. Barberan-Soler S, Zahler AM (2008) Alternative splicing regulation during C. elegans development: splicing factors as regulated targets. PLoS Genetics 4(2):e1000001. doi: 10.1371/journal.pgen.1000001
44. Kornblihtt AR (2007) Coupling transcription and alternative splicing. Adv Exp Med Biol 623:175-189
45. Grabowski PJ, Black DL (2001) Alternative RNA splicing in the nervous system. Prog Neurobiol 65(3):289-308
46. Stamm S (2002) Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. Hum Mol Genet 11(20):2409-2416
47. Pick M, Flores-Flores C, Soreq H (2004) From brain to blood: alternative splicing evidence for the cholinergic basis of Mammalian stress responses. Ann N Y Acad Sci 1018:85-98. doi: 10.1196/annals.1296.010
48. Jin Y, Gallagher PJ (2003) Antisense depletion of death-associated protein kinase promotes apoptosis. J Biol Chem 278(51):51587-51593. doi: 10.1074/jbc.M309165200
49. Jin Y, Blue EK, Gallagher PJ (2006) Control of death-associated protein kinase (DAPK) activity by phosphorylation and proteasomal degradation. J Biol Chem 281(51):39033-39040. doi: 10.1074/jbc.M605097200
50. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281-297
51. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5(7):522-531. doi: 10.1038/nrg1379
52. Chen HY, Lin YM, Chung HC, Lang YD, Lin CJ, Huang J, Wang WC, Lin FM, Chen Z, Huang HD, Shyy JY, Liang JT, Chen RH (2012) miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res 72(14):3631-3641. doi: 10.1158/0008-5472.CAN-12-0667
53. Merhavi E, Cohen Y, Avraham BC, Frenkel S, Chowers I, Pe'er J, Goldenberg-Cohen N (2007) Promoter methylation status of multiple genes in uveal melanoma. Invest Ophthalmol Vis Sci 48(10):4403-4406. doi: 10.1167/iovs.07-0272
54. Hou P, Ji M, Yang B, Chen Z, Qiu J, Shi X, Lu Z (2006) Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma. Cancer 106(7):1602-1609. doi: 10.1002/cncr.21762
55. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61(8):3225-3229
56. Roman-Gomez J, Jimenez-Velasco A, Castillejo JA, Agirre X, Barrios M, Navarro G, Molina FJ, Calasanz MJ, Prosper F, Heiniger A, Torres A (2004) Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood 104(8):2492-2498. doi: 10.1182/blood-2004-03-0954
57. Gao Y, Guan M, Su B, Liu W, Xu M, Lu Y (2004) Hypermethylation of the RASSF1A gene in gliomas. Clinica Chimica Acta 349(1-2):173-179. doi: 10.1016/j.cccn.2004.07.006
58. Xiaofang L, Kun T, Shaoping Y, Zaiqiu W, Hailong S (2012) Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma. World J Surg Oncol 10:5. doi: 10.1186/1477-7819-10-5
59. Hoon DS, Spugnardi M, Kuo C, Huang SK, Morton DL, Taback B (2004) Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients. Oncogene 23(22):4014-4022. doi: 10.1038/sj.onc.1207505
60. Rastetter M, Schagdarsurengin U, Lahtz C, Fiedler E, Marsch W, Dammann R, Helmbold P (2007) Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma. Histol Histopathol 22(9):1005-1015
61. Maruyama R, Toyooka S, Toyooka KO, Virmani AK, Zochbauer-Muller S, Farinas AJ, Minna JD, McConnell J, Frenkel EP, Gazdar AF (2002) Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 8(2):514-519
62. Yamanaka M, Watanabe M, Yamada Y, Takagi A, Murata T, Takahashi H, Suzuki H, Ito H, Tsukino H, Katoh T, Sugimura Y, Shiraishi T (2003) Altered methylation of multiple genes in carcinogenesis of the prostate. Int J Cancer 106(3):382-387. doi: 10.1002/ijc.11227
63. Lin HY, Huang TT, Lee MS, Hung SK, Lin RI, Tseng CE, Chang SM, Chiou WY, Hsu FC, Hsu WL, Liu DW, Su YC, Li SC, Chan MW (2013) Unexpected close surgical margin in resected buccal cancer: very close margin and DAPK promoter hypermethylation predict poor clinical outcomes. Oral Oncology 49(4):336-344. doi: 10.1016/j.oraloncology.2012.11.005
64. Hafner N, Diebolder H, Jansen L, Hoppe I, Durst M, Runnebaum IB (2011) Hypermethylated DAPK in serum DNA of women with uterine leiomyoma is a biomarker not restricted to cancer. Gynecol Oncol 121(1):224-229. doi: 10.1016/j.ygyno.2010.11.018
65. Wu LM, Zhang F, Zhou L, Yang Z, Xie HY, Zheng SS (2010) Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation. BMC Cancer 10:399. doi: 10.1186/1471-2407-10-399
66. Sugita H, Iida S, Inokuchi M, Kato K, Ishiguro M, Ishikawa T, Takagi Y, Enjoji M, Yamada H, Uetake H, Kojima K, Sugihara K (2011) Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer. Oncol Rep 25(2):513-518. doi: 10.3892/or.2010.1085
67. Ben Ayed-Guerfali D, Benhaj K, Khabir A, Abid M, Bayrouti MI, Sellami-Boudawara T, Gargouri A, Mokdad-Gargouri R (2011) Hypermethylation of tumor-related genes in Tunisian patients with gastric carcinoma: clinical and biological significance. J Surg Oncol 103(7):687-694. doi: 10.1002/jso.21875
68. Peng Z, Shan C, Wang H (2010) Value of promoter methylation of RASSF1A, p16, and DAPK genes in induced sputum in diagnosing lung cancers. Zhong Nan Da Xue Xue Bao Yi Xue Ban 35(3):247-253. doi: 10.3969/j.issn.1672-7347.2010.03.010
69. Narayan G, Arias-Pulido H, Koul S, Vargas H, Zhang FF, Villella J, Schneider A, Terry MB, Mansukhani M, Murty VV (2003) Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer 2:24
70. Niyazi M, Liu XW, Zhu KC (2012) Death-associated protein kinase promoter (DAPK) hypermethylation in uterine cervical cancer and intraepithelial neoplasia in Uyghur nationality women. Zhonghua zhong liu za zhi [Chinese journal of oncology] 34(1):31-34
71. Christoph F, Weikert S, Kempkensteffen C, Krause H, Schostak M, Kollermann J, Miller K, Schrader M (2006) Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications. Clin Cancer Res 12(17):5040-5046. doi: 10.1158/1078-0432.CCR-06-0144
72. Ahmad ST, Arjumand W, Seth A, Saini AK, Sultana S (2012) Methylation of the APAF-1 and DAPK-1 promoter region correlates with progression of renal cell carcinoma in North Indian population. Tumour Biol 33(2):395-402. doi: 10.1007/s13277-011-0235-9
73. Jing F, Yuping W, Yong C, Jie L, Jun L, Xuanbing T, Lihua H (2010) CpG island methylator phenotype of multigene in serum of sporadic breast carcinoma. Tumour Biol 31(4):321-331. doi: 10.1007/s13277-010-0040-x
74. Botezatu A, Goia-Rusanu CD, Iancu IV, Huica I, Plesa A, Socolov D, Ungureanu C, Anton G (2011) Quantitative analysis of the relationship between microRNA124a, -34b and -203 gene methylation and cervical oncogenesis. Mol Med Rep 4(1):121-128. doi: 10.3892/mmr.2010.394
75. Jablonowski Z, Reszka E, Gromadzinska J, Wasowicz W, Sosnowski M (2011) Hypermethylation of p16 and DAPK promoter gene regions in patients with non-invasive urinary bladder cancer. Arch Med Sci 7(3):512-516. doi: 10.5114/aoms.2011.23421
76. Sun W, Zaboli D, Wang H, Liu Y, Arnaoutakis D, Khan T, Khan Z, Koch WM, Califano JA (2012) Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer. Clin Cancer Res 18(4):1082-1091. doi: 10.1158/1078-0432.CCR-11-2392
77. Steinmann K, Sandner A, Schagdarsurengin U, Dammann RH (2009) Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma. Oncol Rep 22(6):1519-1526
78. Krajnovic M, Radojkovic M, Davidovic R, Dimitrijevic B, Krtolica K (2013) Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma. Med Oncol 30(1):441. doi: 10.1007/s12032-012-0441- 3
79. Kim JC, Choi JS, Roh SA, Cho DH, Kim TW, Kim YS (2010) Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas. Ann Surg Oncol 17(7):1767-1776. doi: 10.1245/s10434-009-0901-y